Zydus Phils Inc - Результати пошуку

ПАР - англійська - South African Health Products Regulatory Authority (SAHPRA)

zydus fluconazole 150 mg capsules

zydus healthcare (pty) ltd - capsules - see ingredients - each capsule contains fluconazole 150,0 mg

ПАР - англійська - South African Health Products Regulatory Authority (SAHPRA)

zydus topiramate sprinkles 25 capsules

zydus healthcare (pty) ltd - capsules - see ingredients - each sprinkle capsule contains topiramate 25,0 mg

США - англійська - NLM (National Library of Medicine)

teriflunomide tablet, film coated

zydus pharmaceuticals usa inc. - teriflunomide (unii: 1c058ikg3b) (teriflunomide - unii:1c058ikg3b) - teriflunomide is indicated for the treatment of relapsing forms of multiple sclerosis (ms), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. teriflunomide is contraindicated in/with: - patients with severe hepatic impairment [see warnings and precautions (5.1)] . - pregnant women and females of reproductive potential not using effective contraception. teriflunomide may cause fetal harm [see warnings and precautions (5.2 and 5.3) and use in specific populations (8.1)] . - patients with a history of a hypersensitivity reaction to teriflunomide, leflunomide, or to any of the inactive ingredients in teriflunomide. reactions have included anaphylaxis, angioedema, and serious skin reactions [see warnings and precautions (5.5)]. - coadministration with leflunomide [see clinical pharmacology (12.3)]. risk summary teriflunomide is contraindicated for use in pregnant women and females of reproductive po